(S (NP (NNP Lung) (NN cancer)) (VP (VBZ continues) (S (VP (TO to) (VP (VB be) (NP (DT a) (JJ major) (NN healthcare) (NN challenge)) (PP (IN with) (NP (NP (JJ high) (NN morbidity) (CC and) (NN mortality) (NNS rates)) (PP (PP (IN among) (NP (DT both) (NNS men) (CC and) (NNS women))) (ADVP (RB worldwide))))))))) (. .))
(S (NP (NP (DT The) (NN majority)) (PP (IN of) (NP (NN lung) (NN cancer) (NNS cases)))) (VP (VBP are) (PP (IN of) (NP (JJ non-small) (NN cell) (NN lung) (NN cancer) (NN type)))) (. .))
(S (PP (IN With) (NP (NP (DT the) (NN advent)) (PP (IN of) (NP (JJ targeted) (NN cancer) (NN therapy))))) (, ,) (NP (NP (PRP it))) (VP (VBZ is) (ADJP (JJ imperative)) (S (ADVP (RB not) (RB only)) (VP (TO to) (VP (ADVP (RB properly)) (VB diagnose) (CC but) (RB also) (JJ sub-classify) (NP (JJ non-small) (NN cell) (NN lung) (NN cancer)))))) (. .))
(S (PP (IN In) (NP (PRP$ our) (NN study))) (, ,) (NP (PRP we)) (VP (VBD evaluated) (NP (NP (DT the) (NN utility)) (PP (IN of) (S (VP (VBG using) (NP (NNP Apple) (NNP Create) (NNP ML) (NN module)) (S (VP (TO to) (VP (VB detect) (CC and) (VB sub-classify) (NP (JJ non-small) (NN cell) (NNS carcinomas)) (PP (VBN based) (PP (IN on) (NP (JJ histopathological) (NNS images)))))))))))) (. .))
(S (PP (IN After) (NP (NN module) (NN optimization))) (, ,) (NP (DT the) (NN program)) (VP (VP (VBD detected) (NP (NP (CD 100) (NN %)) (PP (IN of) (NP (JJ non-small) (NN cell) (NN lung) (NN cancer) (NNS images))))) (CC and) (VP (ADVP (RB successfully)) (VBD subclassified) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (DT the) (NNS images)))))) (. .))
(S (NP (NP (JJ Trained) (NNS modules)) (, ,) (PP (JJ such) (IN as) (NP (NNS ours))) (, ,)) (VP (MD can) (VP (VB be) (VP (VBN utilized) (PP (IN in) (NP (JJ diagnostic) (JJ smartphone-based) (NNS applications))) (, ,) (S (VP (VBG augmenting) (NP (NP (JJ diagnostic) (NNS services)) (PP (IN in) (NP (NP (JJ understaffed) (NNS areas)) (PP (IN of) (NP (DT the) (NN world))))))))))) (. .))
